Nanologica: Q4 is a quarter with low sales activity - Redeye

The combination with easing COVID restrictions and the access to funds via Flerie Invest AB is a good combination that gives Nanologica an extended window of opportunity to establish sales and a commercial pipeline of interest in preparative chromatography. However, this is also a necessity that the low sales activity in Q4 confirms.

Länk till analysen i sin helhet: https://www.redeye.se/research/832196/nanologica-q4-is-a-quarter-with-low-sales-activity?utm_source=finwire&utm_medium=RSS